financetom
Business
financetom
/
Business
/
Waters Q4 Adjusted Earnings, Net Sales Rise; Q1, 2025 Earnings Outlook Set
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Waters Q4 Adjusted Earnings, Net Sales Rise; Q1, 2025 Earnings Outlook Set
Feb 12, 2025 3:46 AM

06:28 AM EST, 02/12/2025 (MT Newswires) -- Waters (WAT) reported Q4 adjusted earnings Wednesday of $4.10 per diluted share, up from $3.62 a year earlier.

Analysts polled by FactSet expected $4.03.

Net sales for the quarter ended Dec. 31 were $872.7 million, compared with $819.5 million a year earlier. Analysts surveyed by FactSet expected $857.1 million.

The company expects Q1 adjusted earnings of $2.17 to $2.25 per diluted share. Analysts polled by FactSet expect $2.41.

Waters said it expects full-year 2025 adjusted earnings of $12.70 to $13 per diluted share. Analysts surveyed by FactSet predict $12.82.

Shares were down nearly 4% in premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
3M's PFAS Uncertainty, Free Cash Flow Constraints Temper Optimism Amid Positive Sentiment, UBS Says
3M's PFAS Uncertainty, Free Cash Flow Constraints Temper Optimism Amid Positive Sentiment, UBS Says
Jun 24, 2024
03:44 PM EDT, 06/24/2024 (MT Newswires) -- 3M ( MMM ) has been riding on a wave of positive investor sentiment spurred by several factors including the recent appointment of a new chief executive, but caution is necessary, UBS said in a note Monday. The appointment of Bill Brown as CEO, progress on per- and polyfluoroalkyl substances, or PFAS, cleanup...
Novo Nordisk CEO's testimony before US Senate panel set for Sept. 24
Novo Nordisk CEO's testimony before US Senate panel set for Sept. 24
Jun 24, 2024
WASHINGTON, June 24 (Reuters) - Novo Nordisk chief executive Lars Jorgensen's testimony before the U.S. Senate health committee on U.S. prices for weight loss drugs Ozempic and Wegovy will take place on Sept. 24, committee chairman Senator Bernie Sanders said on Monday.e The Senate Committee on Health, Education, Labor, and Pensions had said earlier this month that Jorgensen agreed to...
Franklin Resources Insider Bought Shares Worth $4,559,040, According to a Recent SEC Filing
Franklin Resources Insider Bought Shares Worth $4,559,040, According to a Recent SEC Filing
Jun 24, 2024
03:57 PM EDT, 06/24/2024 (MT Newswires) -- Charles B Johnson, 10% Owner, on June 21, 2024, executed a purchase for 200,000 shares in Franklin Resources ( BEN ) for $4,559,040. Following the Form 4 filing with the SEC, Johnson has control over a total of 92,786,533 shares of the company, with 88,703,192 shares held directly and 4,083,341 controlled indirectly. SEC...
Sector Update: Consumer
Sector Update: Consumer
Jun 24, 2024
03:24 PM EDT, 06/24/2024 (MT Newswires) -- Consumer stocks were mixed late Monday afternoon, with the Consumer Staples Select Sector SPDR Fund (XLP) increasing 0.9% and the Consumer Discretionary Select Sector SPDR Fund (XLY) down 0.1%. In corporate news, Sony's ( SONY ) Sony Music, Warner Music's ( WMG ) Warner Records and Universal Music are seeking damages from artificial...
Copyright 2023-2026 - www.financetom.com All Rights Reserved